BCL6-IN-10
BCL6-IN-10 is a molecular glue inhibitor targeting the BCL6 BTB domain with an IC50 of 4 nM. BCL6-IN-10 blocks the interaction between BCL6 and transcriptional co-repressors, and induces partial degradation of BCL6 via the ubiquitin-proteasome pathway, thereby de-repressing BCL6 target genes and inhibiting cancer cell proliferation. BCL6-IN-10 can be used in the research of diffuse large B-cell lymphoma.
For research use only. We do not sell to patients.
- CAS No.: 2230406-52-5
- Formula: C22H23ClF2N6O3
- Molecular Weight:492.91
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
BCL6-IN-10 (compound 6) (5 μM; 90 min) acts as a partial BCL6 degrader in SU-DHL-4 diffuse large B-cell lymphoma (DLBCL) cells[1].
BCL6-IN-10 induces the derepression of BCL6 target genes in SU-DHL-4 diffuse large B-cell lymphoma (DLBCL) cells[1].
BCL6-IN-10 potently inhibits the interaction between the BCL6 BTB domain and corepressor peptides, with an IC50 of 4 nM [1].
BCL6-IN-10 inhibits the BCL6-corepressor interaction in mammalian cells with an IC50 of 128 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2230406-52-5
-
Molecular Weight 492.91
-
Formula C22H23ClF2N6O3
-
SMILES
CNC(COC1=CC2=CC(NC3=NC(N4CCC(F)(CC4)F)=NC=C3Cl)=CC=C2N(C1=O)C)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)